Related Experiment Videos

Cross-protection studies with Pasteurella multocida bacterins prepared from bacteria propagated in iron-depleted

J R Glisson1, M D Contreras, I H Cheng

  • 1Department of Avian Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602.

Avian Diseases
|October 1, 1993
PubMed

Insights

Iron-deprived Pasteurella multocida vaccines did not consistently protect chickens and turkeys against different serotypes. Further research is needed to improve avian Pasteurella multocida vaccine efficacy.

Area of Science:

  • Veterinary microbiology
  • Immunology

Background:

  • Pasteurella multocida is a significant pathogen in avian species.
  • Outer membrane proteins (MPs) are crucial for bacterial virulence and immune response.
  • Iron availability influences bacterial gene expression and protein profiles.

Purpose of the Study:

  • To investigate the immunogenicity of Pasteurella multocida grown under iron-restricted conditions.
  • To evaluate the potential of iron-regulated MPs for inducing heterologous serotype immunity in poultry.

Main Methods:

  • Two strains of Pasteurella multocida (serotypes 1 and 3) were cultured in iron-depleted media using chelators.
  • Bacterial cells expressing unique MPs were used to create inactivated oil-emulsion vaccines.
  • Chickens and turkeys were vaccinated twice and subsequently challenged with homologous and heterologous serotypes.

Main Results:

  • Culturing Pasteurella multocida in iron-depleted broth induced the expression of additional membrane proteins.
  • Vaccination with bacterins from iron-deprived cultures did not consistently provide significant protection against heterologous serotype challenge.
  • The induced immunity was not reliably effective across different serotypes.

Conclusions:

  • Bacterins derived from iron-regulated Pasteurella multocida outer membrane proteins do not consistently induce broad-spectrum heterologous serotype immunity in poultry.
  • Current strategies of using iron-regulated proteins for vaccine development may require further optimization for effective cross-protection against avian Pasteurella multocida infections.

Related Concept Videos